MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,322 Cr | ₹4,446 Cr | ₹2,461 Cr | ₹1,780 Cr | ₹2,526 Cr |
What is the latest Net Current Assets ratio of MANKIND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,322 Cr |
| Mar2024 | ₹4,446 Cr |
| Mar2023 | ₹2,461 Cr |
| Mar2022 | ₹1,780 Cr |
| Mar2021 | ₹2,526 Cr |
How is Net Current Assets of MANKIND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,322 Cr | -70.26 | |
| Mar2024 | ₹4,446 Cr | 80.62 | |
| Mar2023 | ₹2,461 Cr | 38.25 | |
| Mar2022 | ₹1,780 Cr | -29.52 | |
| Mar2021 | ₹2,526 Cr | - | |
Compare Net Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,536.5 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.8% |
6.7% |
8% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses